Literature DB >> 15644953

Hyperpolarization of murine small caliber mesenteric arteries by activation of endothelial proteinase-activated receptor 2.

John J McGuire1, Morley D Hollenberg, Brian M Bennett, Chris R Triggle.   

Abstract

Activation of endothelial proteinase-activated receptor 2 (PAR-2) relaxes vascular smooth muscle (VSM) and causes hypotension by nitric oxide (NO)-prostanoid-dependent and -independent mechanisms. We investigated whether endothelium-dependent hyperpolarization of VSM was the mechanism whereby resistance caliber arteries vasodilated independently of NO. VSM membrane potentials and isometric tension were measured concurrently to correlate the electrophysiological and mechanical changes in murine small caliber mesenteric arteries. In uncontracted arteries, the PAR-2 agonist, SLIGRL-NH2 (0.1 to 10 micromol/L), hyperpolarized the VSM membrane potential only in endothelium-intact arterial preparations. This response was unaltered by treatment of arteries with inhibitors of NO synthases (L-NAME), soluble guanylyl cyclase (ODQ), and cyclooxygenases (indomethacin). L-NAME, ODQ, and indomethacin also failed to inhibit SLIGRL-NH2-induced hyperpolarization and of cirazoline-contracted mesenteric arteries. However, in blood vessels that were depolarized and contracted with 30 mmol/L KCl, the effects of the SLIGRL-NH2 on membrane potential and tension were not observed. SLIGRL-NH2-induced hyperpolarization and relaxation was inhibited completely by the combination of apamin plus charybdotoxin, but only partially inhibited after treatment with the combination of barium plus ouabain, suggesting an important role for SKCa and IKCa channels and a lesser role for Kir channels and Na+/K+ ATPases in the hyperpolarization response. We concluded that activation of endothelial PAR-2 hyperpolarized the vascular smooth muscle (VSM) cells of small caliber arteries, without requiring the activation of NO synthases, cyclooxygenases, or soluble guanylyl cyclase. Indeed, this hyperpolarization may be a primary mechanism for PAR-2-induced hypotension in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15644953     DOI: 10.1139/y04-121

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  16 in total

1.  Proteinase-activated receptors 1 and 2 and the regulation of porcine coronary artery contractility: a role for distinct tyrosine kinase pathways.

Authors:  Mahmoud El-Daly; Mahmoud Saifeddine; Koichiro Mihara; Rithwik Ramachandran; Christopher R Triggle; Morley D Hollenberg
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

2.  Heat shock protein-27 and sex-selective regulation of muscarinic and proteinase-activated receptor 2-mediated vasodilatation: differential sensitivity to endothelial NOS inhibition.

Authors:  Vivek Krishna Pulakazhi Venu; Mahmoud Saifeddine; Koichiro Mihara; Mahmoud El-Daly; Darrell Belke; Jonathan L E Dean; Edward R O'Brien; Simon A Hirota; Morley D Hollenberg
Journal:  Br J Pharmacol       Date:  2018-04-25       Impact factor: 8.739

Review 3.  Endothelial control of vasodilation: integration of myoendothelial microdomain signalling and modulation by epoxyeicosatrienoic acids.

Authors:  David C Ellinsworth; Scott Earley; Timothy V Murphy; Shaun L Sandow
Journal:  Pflugers Arch       Date:  2013-06-08       Impact factor: 3.657

4.  Persistence of PAR-2 vasodilation despite endothelial dysfunction in BPH/2 hypertensive mice.

Authors:  John J McGuire; Bruce N Van Vliet; José Giménez; James C King; Sarah J Halfyard
Journal:  Pflugers Arch       Date:  2007-02-23       Impact factor: 3.657

5.  GPCR-mediated EGF receptor transactivation regulates TRPV4 action in the vasculature.

Authors:  Mahmoud Saifeddine; Mahmoud El-Daly; Koichiro Mihara; Nigel W Bunnett; Peter McIntyre; Christophe Altier; Morley D Hollenberg; Rithwik Ramachandran
Journal:  Br J Pharmacol       Date:  2015-03-18       Impact factor: 8.739

6.  Endothelial dysfunction in the streptozotocin-induced diabetic apoE-deficient mouse.

Authors:  Hong Ding; Michael Hashem; William B Wiehler; Winnie Lau; Jacqueline Martin; Julianne Reid; Chris Triggle
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

Review 7.  Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems.

Authors:  Kristina K Hansen; Katerina Oikonomopoulou; Yang Li; Morley D Hollenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-19       Impact factor: 3.000

8.  C-type natriuretic peptide and endothelium-dependent hyperpolarization in the guinea-pig carotid artery.

Authors:  V Leuranguer; P M Vanhoutte; T Verbeuren; M Félétou
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

9.  Enhanced K(+)-channel-mediated endothelium-dependent local and conducted dilation of small mesenteric arteries from ApoE(-/-) mice.

Authors:  Timea Beleznai; Hiromichi Takano; Claire Hamill; Polina Yarova; Gillian Douglas; Keith Channon; Kim Dora
Journal:  Cardiovasc Res       Date:  2011-06-20       Impact factor: 10.787

10.  Preserved arterial vasodilatation via endothelial protease-activated receptor-2 in obese type 2 diabetic mice.

Authors:  Satomi Kagota; Elizabeth Chia; John J McGuire
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.